Company Overview and News

 
KLCI remains in negative zone as regional markets retreat

2016-03-21 theedgemarkets
KUALA LUMPUR (March 21): The FBM KLCI remained in negative territory at mid-morning today in line with the retreat at most regional markets.

 
KLCI opens lower, support seen at 1,700-points

2016-03-21 theedgemarkets
KUALA LUMPUR (March 21): The FBM KLCI opened lower this morning with support seen at 1,700-point level.

 
Breakfast briefing: Tuesday, March 15

2016-03-15 thestar.com.my
MarketWrap: Wall Street closed little changed in light trading on Monday as consumer discretionary gains countered losses in energy shares and investors laid low ahead of a US Federal Reserve meeting. The Fed is not expected to raise interest rates at the two-day meeting, which begins on Tuesday, but investors will be on the lookout for clues about future hikes. - Reuters DJIA closed up 15.82 points, or 0.

 
KLCI lifted by gains at global markets

2016-03-14 themalaysianoutsider
The FBM KLCI remained in positive territory at the midday break today, lifted by gains at most global markets.

 
KLCI lifted by gains at global markets

2016-03-14 theedgemarkets
KUALA LUMPUR (March 14): The FBM KLCI remained in positive territory at the midday break today, lifted by gains at most global markets.

 
KLCI retreats as regional markets dip

2016-03-09 themalaysianoutsider
The FBM KLCI retreated at the midday break today in line with the profit taking at most regional markets. At 12.30pm, the FBM KLCI fell 5.50 points to…

 
KLCI advances in line with regional gains

2016-03-01 theedgemarkets
KUALA LUMPUR (March 1): The FBM KLCI advanced at the midday break today in line with gains at regional markets, lifted by select blue chips. At 12.30pm, the FBM KLCI rose 7.71 points to 1,662.46. Losers outpaced gainers by 391 to 308, while 315 counters traded unchanged. Volume was 840.44 million shares, valued at RM582.97 million.

 
KLCI remains in positive zone, gains seen limited

2016-03-01 theedgemarkets
KUALA LUMPUR (March 1): The FBM KLCI extended its gains, albeit in limited fashion at mid-morning today, lifted by select blue chips. At 10.01am, the FBM KLCI was up 5.29 points to 1,660.04. The top gainers included United Plantations Bhd, Kuala Lumpur Kepong Bhd, PPB Group Bhd, Dutch Lady Milk Industries Bhd, Petron Malaysia Refining & Marketing Bhd, Allianz Malaysia Bhd,Guiness Anchor Bhd, Malayan Banking Bhd and Hap Seng Consolidated Bhd.

 
KLCI extends loss as crude skids

2016-02-24 theedgemarkets
KUALA LUMPUR (Feb 24): The FBM KLCI extended its losses at the midday break today as regional markets stayed sluggish on declining crude oil prices. At 12.30pm, the FBM KLCI fell 9.55 points to 1,667.73. Losers thumped gainers by 554 to 164, while 274 counters traded unchanged. Volume was 706.26 million shares valued at RM594.16 million.

 
KLCI opens higher, key blue chips lift

2016-02-15 themalaysianinsider
The FBM KLCI opened higher today, lifted by key blue chip stocks. At 9am, the FBM KLCI rose 8.91 points to 1,652.65. The top gainers included Petronas…

 
KLCI opens higher, key blue chips lift

2016-02-15 theedgemarkets
KUALA LUMPUR (Feb 15): The FBM KLCI opened higher today, lifted by key blue chip stocks. At 9am, the FBM KLCI rose 8.91 points to 1,652.65. The top gainers included Petronas Gas Bhd, British American Tobacco (M) Bhd, Can-One Bhd, Tenaga Nasional Bhd, Focus Lumber Bhd, Cahya Mata Sarawak Bhd, Hartalega Holdings Bhd, KLCC Property Holdings Bhd, Maxis Bhd and SapuraKencana Petroleum Bhd.

 
KLCI pares loss, stays down in line with global weakness

2016-02-11 themalaysianinsider
The FBM KLCI pared some of its losses at the midday break today but remained in the red in line with global equity markets’ weakness. At 12.30pm,…

 
KLCI pares loss, stays down in line with global weakness

2016-02-11 theedgemarkets
KUALA LUMPUR (Feb 11): The FBM KLCI pared some of its losses at the midday break today but remained in the red in line with global equity markets’ weakness. At 12.30pm, the FBM KLCI was down 2.63 points to 1,641.78. The index had earlier slipped to its intra morning low of 1,638.88. Losers outpaced gainers by 379 to 195, while 266 counters traded unchanged. Volume was 644.83 million shares valued at RM483.

 
High Court orders Kian Joo to pay former ED RM8.82m

2016-01-21 theedgemarkets
KUALA LUMPUR (Jan 21): The Kuala Lumpur High Court has ordered Kian Joo Can Factory Bhd (KJCF), Kian Joo Packaging Sdn Bhd and KJ Can (Selangor) Sdn Bhd to pay RM8.82 million in retirement gratuity, contractual bonus and arrears of salary, to KJCF former executive director (ED) See Teow Koon until June 14, 2019 when he attains the age of 70.

 
KLCI stays in negative zone as regional markets retreat

2016-01-20 theedgemarkets
KUALA LUMPUR (Jan 20): The FBM KLCI stayed in the negative zone at the midday break today, in line with the regional markets that retreated. Sentiment at the local bourse also remained tepid, as investors turned bearish. At 12.30pm, the FBM KLCI fell 6.87 points to 1,622.35. Losers hammered gainers by 706 to 141, while 248 counters traded unchanged. Volume was 1.24 billion shares, valued at RM909.93 million.

Related Articles

ANTH: Anthera Pharmaceuticals Analysis and Research Report

2018-05-21 - Asif

Overview Anthera Pharmaceuticals, Inc. is a biopharmaceutical company focused on advancing the development and commercialization of innovative medicines that benefit patients with unmet medical needs. The company currently have two compounds in development, Sollpura and blisibimod. The company licensed Sollpura from Eli Lilly & Co (“Eli Lilly”) in July 2014. Sollpura is a novel non-porcine investigational Pancreatic Enzyme Replacement Therapy (“PERT”) intended for the treatment of patients with Exocrine Pancreatic Insufficiency (“EPI”), often seen in patients with cystic fibrosis and other conditions. The company licensed blisibimod from Amgen, Inc. (“Amgen”) in December 2007. Blisibimod targets B-cell activating factor, or BAFF, which has been shown to be elevated in a variety of B-cell mediated autoimmune diseases, including Immunoglobulin A nephropathy, or IgA nephropathy. Sollpura The exocrine pancreas is responsible for synthesis and secretion of digestive en...

AGEN: Agenus Inc Analysis and Research Report

2018-05-21 - Asif

Business Agenus is a clinical-stage immuno-oncology (“I-O”) company dedicated to becoming a leader in the discovery and development of innovative combination therapies and committed to bringing effective medicines to patients with cancer. The company's business is designed to drive success in I-O through speed, innovation, and effective combination therapies. Agenus has assembled fully integrated capabilities from novel target discovery, antibody generation, cell line development, and good manufacturing practice (“GMP”) manufacturing together with a comprehensive portfolio consisting of antibody-based therapeutics, adjuvants and cancer vaccine platforms. The company leverage its immune biology platforms to identify effective combination therapies for development and have developed productive partnerships to advance its innovation. The company believe the next generation of cancer treatment will build on clinically validated antibodies targeting CTLA-4 and PD-1 combined wi...

SQ: Square Analysis and Research Report

2018-05-21 - Asif

Business The company started Square in February 2009 to enable businesses (sellers) to accept card payments, an important capability that was previously inaccessible to many businesses. However, sellers also need innovative solutions to thrive, and Square has since expanded to provide additional products and services to give these businesses access to the same tools as large businesses. This approach aligns with its purpose of economic empowerment, as everything the company do should give sellers accessible, affordable tools to grow their businesses and participate in the economy. Square is a cohesive commerce ecosystem that helps its sellers start, run, and grow their businesses. The company combine sophisticated software with affordable hardware to enable sellers to turn mobile and computing devices into powerful payment and point-of-sale solutions. Square has high seller acceptance rates and fast onboarding, while maintaining low risk and fraud losses as a result of its a...